Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer

Conditions:   Merkel Cell Carcinoma;   Small Cell Lung Cancer Interventions:   Biological: XmAb18087;   Drug: XmAb18087 ± Pembrolizumab Sponsors:   Xencor, Inc.;   ICON plc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials